IDO1 and major depressive disorder: A recent study has shown that IDO1 expression in mice is upregulated by LPS in the PFC but not in the hippocampus, and microinjection of 1-MT (a potent IDO1 antagonist) or microRNA-874-3p into the PFC downregulates LPS-induced IDO1 expression and ameliorates LPS-induced depression-like behavior, thus revealing that microRNA-874-3p is a novel potential target for the treatment of MDD (Suento et al., 2020).